Therapeutic Solutions International, Inc. · OTC:TSOI

Therapeutic Solutions International, Inc. financial statements

Therapeutic Solutions International, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue99.0K206.8K146.0K62.7K27.5K3.48K2.85K1.91K268.9K0
Cost of revenue36.8K79.4K42.5K12.8K3.02K2.16K8233.19K26.8K0
Gross profit62.2K127.3K103.4K49.9K24.5K1.33K2.03K-1.28K242.1K0
Research and development560.7K1.44M794.8K562.0K27.7K75.0K25.1K11.0K11.0K11.0K
Selling, general and administrative1.05M1.77M1.61M1.34M1.04M1.12M857.9K565.8K306.0K306.0K
Operating income-1.99M-3.28M-2.30M-1.85M-1.04M-1.20M-884.3K-570.9K-327.1K-327.1K
Depreciation and amortization311.8K244.6K18.1K6.98K6.59K195.0K27.5K1.04M21.1K21.1K
EBITDA-1.67M-3.03M-2.29M-1.84M-1.04M-1.00M-856.8K471.2K-306.0K-306.0K
Interest expense423.3K646.1K611.8K302.5K350.7K241.8K53.4K5.55K9.38K0
Income before tax-2.22M-3.88M-2.96M-2.20M-1.70M-1.87M-995.5K-572.6K-537.8K-537.8K
Income tax2.25K1.60K800295.8K350.7K667.1K-830.8K13.8K14.3K0
Net income-2.17M-3.81M-2.96M-2.20M-1.70M-1.87M-995.5K-586.4K-288.8K-288.8K
Earnings per share, basic-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash and equivalents27.8K18.0K94.0K252.1K26.4K22.4K2921.9K2.89K2.89K
Short-term investments0000
Receivables19.2K25.4K16.6K2.44K2.90K-1.05K-14.3K90.0K
Inventory22.6K42.4K39.8K5.40K5.18K01.51K36.4K26.8K
Current assets85.9K309.2K1.12M347.5K139.7K135.9K2.60K72.6K188.8K188.8K
Property, plant and equipment281.7K318.2K64.0K5.62K0000
Goodwill0000
Total assets3.29M3.61M1.72M603.5K311.0K206.9K26.5K104.9K201.2K201.2K
Accounts payable404.9K409.2K403.8K309.7K324.9K320.8K343.8K327.6K290.6K290.6K
Current liabilities1.90M2.21M2.50M2.35M2.35M2.02M1.34M684.2K332.5K332.5K
Long-term debt5.51K10.5K15.5K0075.5K0
Total debt888.1K1.08M1.10M1.04M981.6K504.3K456.7K297.0K30.0K
Total liabilities2.01M2.22M2.52M2.38M2.35M2.02M1.34M759.7K332.5K332.5K
Shareholders' equity1.13M1.22M-805.0K-1.78M-2.04M-1.81M-1.31M-654.8K-131.3K-131.3K
Shares outstanding3.17B2.53B2.26B1.91B1.28B896.9M778.2M668.1M196.4M

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations-1.06M-1.02M-718.9K-663.1K-310.7K-469.2K-366.7K-385.7K-59.6K-332.5K
Capital spending-16.2K-200.0K-260.6K-5.45K-5.45K-5.45K-5.45K000
Free cash flow-1.07M-1.02M-979.5K-668.5K-310.7K-469.2K-366.7K-385.7K-59.6K-332.5K
Cash from investing-24.0K-256.6K-5.45K-5.45K-5.45K-5.45K055.0K55.0K
Cash from financing1.08M943.1K817.4K894.3K314.7K491.5K344.8K405.5K-5.00K267.9K
Dividends paid0000
Share buybacks588.0K01.70K2.82K1.68K202.5K
Change in cash-1.61K-75.2K-158.1K225.8K4.03K22.4K-21.9K19.7K-9.62K-9.62K